Tech Company Financing Transactions
Waypoint Bio Funding Round
Amplify Partners, General Catalyst and Hummingbird Ventures participated in a $20 million Series A capital raise for Waypoint Bio. This VC investment round was announced on 5/27/2026.
Transaction Overview
Company Name
Announced On
5/27/2026
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
180 Varick St, 6th Floor
New York, NY 10014
USA
New York, NY 10014
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
We are pioneering high throughput in vivo testing to develop novel cell therapies for solid tumors, autoimmune diseases, and beyond. Our platform uses ultra-high resolution spatial multi-omics and is powered by proprietary approaches using computer vision, cell therapy design, and pooled screening.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Xinchen Wang
Chief Scientific Officer
David Phizicky
VP - Administration
Tinsley Maier
Browse more venture capital transactions:
Prev: 5/27/2026: Capchase venture capital transaction
Next: 5/27/2026: Olyzon venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC transactions reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs